Maraviroc 150 mg QD plus lopinavir/ritonavir, a NRTI‐sparing regimen for HIV‐infected naïve patients: 48‐weeks final resultsSilvia Nozza, Adriano Lazzarin, Sonja Chiappetta et al.|Journal of the International AIDS Society|2012Cited by 9